These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2104987)

  • 1. Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.
    Gentil V; Tavares S; Gorenstein C; Bello C; Mathias L; Gronich G; Singer J
    Psychopharmacology (Berl); 1990; 100(1):54-9. PubMed ID: 2104987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the benzodiazepine antagonist Ro 15-1788 on flunitrazepam-induced sleep changes.
    Gaillard JM; Blois R
    Br J Clin Pharmacol; 1983 May; 15(5):529-36. PubMed ID: 6134542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flunitrazepam on memory and their reversal by two antagonists.
    Gentil V; Gorenstein C; Camargo CH; Singer JM
    J Clin Psychopharmacol; 1989 Jun; 9(3):191-7. PubMed ID: 2500462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ro 15-1788 antagonizes reliably the Benzodiazepine effect after Flunitrazepam combination anesthesias].
    Tolksdorf W; Pirwitz A; Bentzinger C; Pfeiffer J
    Anaesthesist; 1987 May; 36(5):203-9. PubMed ID: 3115136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    Klotz U; Duka T; Dorow R; Doenicke A
    Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam.
    Lauven PM; Schwilden H; Stoeckel H; Greenblatt DJ
    Anesthesiology; 1985 Jul; 63(1):61-4. PubMed ID: 2861765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of the benzodiazepine antagonist RO 15-1788].
    Ellmauer S; Müller H; Dick W
    Anaesthesist; 1988 Jul; 37(7):432-9. PubMed ID: 3137835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta activation following the intravenous administration of benzodiazepines and the specific antagonist flumazenil (Ro 15-1788)].
    Suttmann H; Rampf U; Juhl G; Greim M; Doenicke A
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1990 Mar; 21(1):20-8. PubMed ID: 1970957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in benzodiazepine-receptor activity modify morphine withdrawal syndrome in mice.
    Valverde O; Micó JA; Maldonado R; Gibert-Rahola J
    Drug Alcohol Depend; 1992 Aug; 30(3):293-300. PubMed ID: 1327709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of benzodiazepine-fentanyl anaesthesia with flumazenil.
    Kaukinen S; Kataja J; Kaukinen L
    Can J Anaesth; 1990 Jan; 37(1):40-5. PubMed ID: 1967226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505.
    Gath I; Weidenfeld J; Collins GI; Hadad H
    Br J Clin Pharmacol; 1984 Oct; 18(4):541-7. PubMed ID: 6435655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
    O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
    Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal.
    Emrich HM; Sonderegger P; Mai N
    Neurosci Lett; 1984 Jun; 47(3):369-73. PubMed ID: 6433243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A behavioral examination of convulsant benzodiazepine and GABA antagonist, Ro 5-3663, and benzodiazepine-receptor antagonist Ro 15-1788.
    Feldon J; Lerner T; Levin D; Myslobodsky M
    Pharmacol Biochem Behav; 1983 Jul; 19(1):39-41. PubMed ID: 6413985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of slow-wave sleep by benzodiazepine antagonist Ro 15-1788.
    Ziegler G; Ludwig L; Fritz G
    Lancet; 1985 Aug; 2(8453):510. PubMed ID: 2863538
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of a specific benzodiazepine antagonist (RO 15-1788) on cerebral blood flow.
    Forster A; Juge O; Louis M; Nahory A
    Anesth Analg; 1987 Apr; 66(4):309-13. PubMed ID: 3105357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical investigation of Ro 15-1788, a benzodiazepine antagonist, in reversing the central effects of flunitrazepam.
    Jensen S; Kirkegaard L; Anderson BN
    Eur J Anaesthesiol; 1987 Mar; 4(2):113-8. PubMed ID: 3109893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute tolerance to diazepam induced by benzodiazepines.
    Wong PT; Yoong YL; Gwee MC
    Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):1-8. PubMed ID: 3086004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in benzodiazepine receptors by acute stress: different effect of chronic diazepam or RO 15-1788 treatment.
    Medina JH; Novas ML; De Robertis E
    Eur J Pharmacol; 1983 Dec; 96(3-4):181-5. PubMed ID: 6327328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.